DEF 14A: Nuvve Holding Corp. Seeks Stockholder Approval for Share Issuance Related to Convertible Notes and Warrants

Nuvve Holding Corp. is holding a special meeting to seek stockholder approval for the issuance of common stock related to convertible notes and warrants, exceeding a previously established share cap.

Summary

• Nuvve Holding Corp. is holding a special meeting on January 13, 2025, to request stockholder approval for issuing shares of common stock related to senior secured convertible notes and warrants.
• The company entered into a Securities Purchase Agreement on October 31, 2024, issuing notes and warrants to investors for $3,375,000.01.
• The notes are convertible into common stock at a price of $3.402 per share, subject to adjustments, and the warrants are exercisable at $3.78 per share.
• The total number of shares that can be issued under the agreement is capped at 19.99% of the outstanding common stock unless stockholder approval is obtained.
• The company is seeking approval to issue shares beyond this 19.99% cap to comply with Nasdaq Listing Rule 5635(d).
• The company intends to use the proceeds from the private placement for working capital and general corporate purposes.
• The notes accrue interest at 8% per annum, increasing to 18% in the event of default, and are payable in monthly installments, potentially in cash or shares of common stock.
• The warrants are exercisable for five years and may be exercised on a cashless basis under certain conditions.
• Investors also have the right to purchase up to an additional $12,500,000 in notes and warrants after six months.
• The company has filed a resale registration statement with the SEC on November 25, 2024, to register the shares for resale by investors.

Sentiment

Score: 6

Explanation: The document is neutral in tone, presenting the facts of the proposed share issuance. While the capital raise is positive, the potential dilution and risks associated with the transaction temper the overall sentiment.

Positives

• The private placement provides Nuvve with $3,375,000.01 in funding for working capital and general corporate purposes.
• The potential exercise of warrants could bring in an additional $4.2 million in gross proceeds.
• The company has secured additional investment rights, allowing for a potential further $12,500,000 in funding.
• The company has taken steps to register the shares for resale by investors, which could improve liquidity.

Negatives

• The issuance of shares will dilute the ownership of existing stockholders.
• The anti-dilution provisions in the notes and warrants could lead to a significant increase in the number of shares issued.
• Failure to obtain stockholder approval could prevent the company from raising additional funds and impact its business plan.
• The company will incur additional expenses and management time if stockholder approval is not obtained and additional meetings are required.
• The market price of the common stock could decline due to the issuance or resale of shares.

Risks

• The company's ability to execute its business plan is dependent on raising additional capital.
• Failure to obtain stockholder approval could limit the company's ability to issue shares and raise funds.
• The anti-dilution provisions in the notes and warrants could significantly increase the number of shares issued.
• The issuance of new shares could cause a decline in the market price of the company's common stock.
• There is no guarantee that investors will exercise their warrants, which could impact the company's funding.

Future Outlook

The company intends to use the net proceeds from the private placement for working capital and general corporate purposes. The company may also seek additional funding through the exercise of the additional investment right by investors.

Management Comments

• The Board recommends a vote FOR the Issuance Proposal and FOR the Adjournment Proposal.
• The company encourages stockholders to attend the virtual special meeting and participate in the vote.

Industry Context

The need for additional capital through private placements is not uncommon for companies in the technology and electric vehicle sectors, especially those in the growth phase. The use of convertible notes and warrants is a common method for raising capital, but it can lead to dilution of existing shareholders. The company's need to seek stockholder approval for exceeding the 20% share issuance threshold is a standard requirement under Nasdaq rules.

Comparison to Industry Standards

• The use of convertible notes and warrants is a common practice for raising capital in the technology and electric vehicle industries, particularly for companies that are not yet profitable.
• The 10% discount on the conversion price of the notes is within the typical range for private placements of this type.
• The anti-dilution provisions in the notes and warrants are also standard, but the full ratchet protection is more aggressive than some other deals.
• The 8% interest rate on the notes is relatively high, reflecting the risk associated with investing in a company that is not yet profitable.
• The additional investment right for investors is a common feature in private placements, allowing investors to increase their stake in the company.

Related Party Transactions

• Gregory Poilasne, the company's CEO and a board member, participated as an investor in the private placement, purchasing $250,000 in notes and warrants.

Stakeholder Impact

• Existing stockholders will experience dilution of their ownership if the share issuance is approved.
• Investors in the private placement stand to benefit from the potential conversion of notes and exercise of warrants.
• The company's ability to raise capital and execute its business plan will be impacted by the outcome of the stockholder vote.

Next Steps

• Stockholders will vote on the Issuance Proposal and the Adjournment Proposal at the Special Meeting on January 13, 2025.
• The company will file a current report on Form 8-K with the SEC to disclose the voting results of the Special Meeting.
• The company will continue to work towards the effective registration of the shares for resale by investors.

Key Dates

Keywords

stockholder approval, convertible notes, warrants, share issuance, private placement, Nasdaq Listing Rule 5635(d), dilution, capital raise, securities purchase agreement, common stock